T. Nabeshima et al. / Tetrahedron 59 (2003) 639–647
645
for C23H38O9·0.5H2O: C, 59.08; H, 8.41. Found: C, 58.73;
H, 8.44.
69.7 (t), 69.4 (t), 68.6 (t), 68.3 (t), 61.6 (t). Anal. calcd for
C36H49BrO12: C, 57.37; H, 6.55. Found: C, 57.09; H, 6.73.
4.2.6. Synthesis of 9a. To a solution of 6a (12.48 g,
33.7 mmol) in dry THF (200 ml) were added NaH (60%
dispersion in oil, 1.498 g, 37.5 mmol) and 8 (5.722 g,
17.3 mmol), and then the mixture was refluxed for 51 h.
After removal of the solvent, H2O (200 ml) was added to the
residue. The mixture was extracted with CHCl3 (3£200 ml),
and the organic phase was dried over anhydrous MgSO4.
The solvent was evaporated, and the crude product was
purified by column chromatography (SiO2, CHCl3/EtOAc¼
1:1) to afford 9a as a yellow oil (13.69 g, 14.9 mmol, 88%).
1H NMR (400 MHz, CDCl3): d (ppm) 7.42 (d, 2H,
J¼7.8 Hz), 7.28 (t, 1H, J¼7.8 Hz), 6.95–6.88 (m, 8H),
4.647 (s, 4H), 4.64–4.60 (m, 2H), 4.19–4.16 (m, 8H),
3.91–3.85 (m, 12H), 3.81–3.79 (m, 4H), 3.76–3.73 (m,
8H), 3.64–3.59 (m, 2H), 3.50–3.47 (m, 2H), 1.83–1.48 (m,
12H). 13C NMR (100 MHz, CDCl3): d (ppm) 149.1 (s),
149.0 (s), 137.9 (s), 127.9 (d), 127.2 (d), 122.6 (s), 121.7 (d),
121.6 (d), 115.1 (d), 115.0 (d), 98.9 (d), 72.7 (t), 70.83 (t),
70.78 (t), 70.3 (t), 69.9 (t), 69.8 (t), 69.0 (t), 68.9 (t), 66.7 (t),
62.2 (t), 30.6 (t), 25.4 (t), 19.5 (t). Anal. calcd for
C46H65BrO14: C, 59.93; H, 7.11. Found: C, 59.81; H, 7.27.
4.2.9. Synthesis of 10b. To a solution of 9b (5.581 g,
5.08 mmol) in EtOH (20 ml) was added 3 M hydrochloric
acid (10 ml), and the mixture was stirred for 48 h at rt. After
addition of saturated aq. NaHCO3 (15 ml), the organic
solvent was evaporated. The mixture was poured into H2O
(30 ml), extracted with CHCl3 (3£40 ml), and the organic
phase was dried over anhydrous MgSO4. After removal of
the solvent, the crude product was purified by column
chromatography (SiO2, EtOAc to EtOAc/EtOH¼5:1) to
1
afford 10b as a yellow oil (4.440 g, 4.78 mmol, 94%). H
NMR (400 MHz, CDCl3): d (ppm) 7.42 (d, 2H, J¼8.0 Hz),
7.29 (t, 1H, J¼8.0 Hz), 6.91 (s, 8H), 4.63 (s, 4H), 4.17 (t,
4H, J¼5.0 Hz), 3.89–3.85 (m, 4H), 3.77–3.66 (m, 36H),
3.61–3.59 (m, 4H), 2.72 (brs, 2H). 13C NMR (100 MHz,
CDCl3): d (ppm) 148.7 (s), 148.6 (s), 137.9 (s), 127.9 (d),
127.2 (d), 122.6 (s), 121.6 (d), 121.5 (d), 114.4 (d), 114.3 (d),
72.71 (t), 72.66 (t), 70.8 (t), 70.7 (t), 70.5 (t), 70.2 (t), 70.1 (t),
69.70 (t), 69.66 (t), 68.6 (t), 68.5 (t), 61.6 (t). Anal. calcd for
C44H65BrO16·H2O: C, 55.75; H, 7.12. Found: C, 55.76; H,
7.17.
4.2.10. Synthesis of 11a. A solution of 8 (2.293 g,
6.69 mmol) and 10a (5.019 g, 6.67 mmol) in dry THF
(100 ml) was added dropwise to a refluxing suspension of
NaH (60% dispersion in oil, 0.587 g, 14.7 mmol) in dry
THF (250 ml) over 24 h, and then the mixture was refluxed
for 48 h. After removal of the solvent, H2O (50 ml) was
added and the mixture was extracted with CHCl3 (3£50 ml).
The organic phase was dried over anhydrous MgSO4, and
the solvent was removed under reduced pressure. The crude
product thus obtained was purified by column chroma-
tography (SiO2, CHCl3 to CHCl3/Et2O/EtOH¼10:10:1) and
recrystallization from EtOAc to afford 11a as a white
powder (3.117 g, 3.34 mmol, 50%). Mp 106.5–108.58C. 1H
NMR (300 MHz, CDCl3): d (ppm) 7.36 (d, 4H, J¼7.8 Hz),
7.24 (t, 2H, J¼7.8 Hz), 6.91 (s, 8H), 4.57 (s, 8H), 4.17 (t,
8H, J¼4.8 Hz), 3.88 (t, 8H, J¼4.8 Hz), 3.78 (t, 8H, J¼
4.6 Hz), 3.68 (t, 8H, J¼4.6 Hz). 13C NMR (100 MHz,
CDCl3): d (ppm) 149.0 (s), 137.9 (s), 127.9 (d), 127.2 (d),
122.6 (s), 121.6 (d), 114.7 (d), 72.7 (t), 70.8 (t), 70.2 (t), 69.9
(t), 69.1 (t). Anal. calcd for C44H54Br2O12: C, 56.54; H,
5.82. Found: C, 56.36; H, 5.92. ESI-MS m/z found:
[MþNa]þ, 955.2, C44H54Br2O12Naþ requires 955.2.
4.2.7. Synthesis of 9b. To a solution of 6b (6.002 g,
13.1 mmol) in dry THF (100 ml) were added NaH (60%
dispersion in oil, 0.680 g, 17.0 mmol) and 8 (2.249 g,
6.56 mmol), and then the mixture was refluxed for 51 h.
After removal of the solvent, H2O (100 ml) was added to the
residue. The mixture was extracted with CHCl3 (3£100 ml),
and the organic phase was dried over anhydrous MgSO4.
The solvent was evaporated, and the crude product was
purified by column chromatography (SiO2, CHCl3/EtOAc¼
1:1) to afford 9b as a yellow oil (6.354 g, 5.79 mmol, 89%).
1H NMR (400 MHz, CDCl3): d (ppm) 7.42 (d, 2H, J¼
7.6 Hz), 7.28 (t, 1H, J¼7.6 Hz), 6.93–6.88 (m, 8H), 4.64–
4.61 (m, 6H), 4.18–4.15 (m, 8H), 3.88–3.84 (m, 12H),
3.77–3.67 (m, 28H), 3.63–3.58 (m, 4H), 1.89–1.45 (m,
12H). 13C NMR (100 MHz, CDCl3): d (ppm) 149.0 (s),
137.9 (s), 127.9 (d), 127.2 (d), 122.6 (s), 121.7 (d), 115.0
(d), 98.9 (d), 72.7 (t), 70.9 (t), 70.8 (t), 70.7 (t), 70.63 (t),
70.58 (t), 70.2 (t), 69.83 (t), 69.81 (t), 68.9 (t), 66.7 (t), 62.2
(t), 30.6 (t), 25.4 (t), 19.5 (t). Anal. calcd for C54H81BrO18·
H2O: C, 58.11; H, 7.50. Found: C, 58.34; H, 7.49.
4.2.8. Synthesis of 10a. To a solution of 9a (3.412 g,
3.70 mmol) in EtOH (20 ml) was added 3 M hydrochloric
acid (10 ml), and the mixture was stirred for 16 h at rt. After
addition of saturated aq. NaHCO3 (15 ml), the organic
solvent was evaporated. The mixture was poured into H2O
(10 ml), extracted with CHCl3 (3£20 ml), and the organic
phase was dried over anhydrous MgSO4. After removal of
the solvent, the crude product was purified by column
chromatography (SiO2, EtOAc to EtOAc/EtOH¼10:1) to
4.2.11. Synthesis of 11b. A solution of 8 (1.498 g,
4.37 mmol) and 10b (4.078 g, 4.39 mmol) in dry THF
(50 ml) was added dropwise to a refluxing suspension of
NaH (60% dispersion in oil, 0.472 g, 11.8 mmol) in THF
(300 ml) over 24 h, and then the mixture was refluxed for
48 h. After removal of the solvent, H2O (50 ml) was added
and the mixture was extracted with CHCl3 (3£50 ml). The
organic phase was dried over anhydrous MgSO4, and the
solvent was removed under reduced pressure. The crude
product was purified by column chromatography (SiO2,
CHCl3 to CHCl3/Et2O/EtOH¼10:10:1) and recrystalliza-
tion from EtOAc to afford 11b as a white powder (2.427 g,
1
afford 10a as a yellow oil (2.311 g, 3.07 mmol, 83%). H
NMR (400 MHz, CDCl3): d (ppm) 7.42 (d, 2H, J¼7.6 Hz),
7.27 (t, 1H, J¼7.6 Hz), 6.92–6.90 (m, 8H), 4.64 (s, 4H),
4.19–4.14 (m, 8H), 3.92 (t, 4H, J¼5.0 Hz), 3.87–3.85 (m,
4H), 3.81–3.79 (m, 4H), 3.77–3.71 (m, 8H), 3.67–3.64 (m,
4H). 13C NMR (100 MHz, CDCl3): d (ppm) 148.7 (s), 148.5
(s), 137.8 (s), 128.0 (d), 127.2 (d), 122.8 (s), 121.6 (d), 121.4
(d), 114.0 (d), 113.9 (d), 72.9 (t), 72.7 (t), 70.7 (t), 70.1 (t),
1
2.19 mmol, 50%). Mp 84.0–85.58C. H NMR (400 MHz,
CDCl3): d (ppm) 8.39 (d, 4H, J¼7.8 Hz), 7.26 (t, 2H, J¼
7.8 Hz), 6.89 (s, 8H), 4.61 (s, 8H), 4.15 (t, 8H, J¼4.8 Hz),
3.86 (t, 8H, J¼5.0 Hz), 3.76–3.67 (m, 32H). 13C NMR